Urologic Robotic Surgery Online Course (2017): Partial Nephrectomy

Welcome to American Urological Association Education and Research, Inc (AUAER)'s online Urologic Robotic Surgery Course, developed by the AUAER Laparoscopic, Robotic Surgery and New Surgical Technology Committee to address the need for a national course/curriculum in urologic robotic surgery. About 80% of all prostatectomies in the USA for the treatment of prostate cancer are being performed with robotic assistance (Su LM. Robot-assisted radical prostatectomy: advances since 2005. Current Opinion in Urology. 20(2):130-5, 2010). There has also been an increased application for pyeloplasty, partial nephrectomy and sacrocolpopexy; and the AUAER core curriculum now includes robotic surgery in one of its sections. However, there is no readily available curriculum for robotic surgery which includes self assessment of knowledge. Residents and urologists need a resource to obtain up-to-date information about robotic surgery of the prostate, kidney, bladder and pelvic floor. They need to learn the surgical techniques for common applications for urologic robotic surgery. The online AUAER Urologic Robotic Surgery Course hopes to meet this educational need that will be of great benefit to trainees and urologists.

Authors:  Firas Petros, MD and Craig Rogers, MD

2015 Reviewers: James Roscoe Porter, MD and Chandru P. Sundaram, MD
2017 Reviewers: Ashok Kumar Hemal, MD and Reza Ghavamian, MD

Target Audience

This enduring material is designed for:

  • Fellows
  • Residents
  • Trainees 

Learning Objectives

After completing this module, the learner should be able to:

  1. Describe the surgical steps involved with the safe performance of robotic partial nephrectomy.
  2. State the indications and contraindications for the robotic approach to urologic surgical procedures.
  3. Identify errors that can occur with the system during robotic surgery conditions.
  4. Describe steps to optimize coordination of bedside assistant
  5. Describe the steps involved with safe operation of the daVinci Surgical System (Intuitive Surgery Inc, Sunnyvale, CA).
  6. Describe complications that can occur during urologic robotic surgery and describe methods to avoid and manage the complications.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
12/12/2017
Course expires: 
12/12/2020
Rating: 
0

Authors Disclosures:
Pasquale Casale, MD: Nothing to disclose
Erik Castle, MD: Consultant or Advisor; Ethicon Endosurgery: Other-Honorarium
George Chow, MD: Nothing to disclose
Sarah P. Conley, MD: Nothing to disclose
Firouz Daneshgari, MD: Nothing to disclose
Jack S. Elder, MD: Nothing to disclose
Daniel S. Elliott, MD: Nothing to disclose
Ahmed Ghazi, MD: Nothing to disclose
Khurshid Guru, MD: Intuitive Surgical, Inc.: Other-Speaker
Jean Joseph, MD, MBA: Nothing to disclose
Jihad Kaouk, MD: Endocare: Meeting Participant or Lecturer; Intuitive Surgical: Consultant or Advisor; Covidien: Consultant or Advisor
Benjamin R. Lee, MD: Cook Urological: Consultant or Advisor
David I. Lee, MD: Intuitive Surgical: Meeting Participant or Lecturer;
Ethicon Endosurgery: Meeting Participant or Lecturer; Pfizer: Scientific Study or Trial; Johnson and Johnson Biopharmaceuticals: Scientific Study or Trial; Aureon: Meeting Participant or Lecturer
Thomas S. Lendvay, MD: Spi Surgical Inc.: Consultant or Advisor
Steven M. Lucas, MD: Nothing to disclose
Mani Menon, MD: Nothing to disclose
Sijo Parekattil, MD: Nothing to disclose
Firas Petros, MD: Nothing to disclose
Raj S. Pruthi, MD, FACS: GTx: Scientific Study or Trial
Craig Rogers, MD: Intuitive Surgical: Consultant or Advisor; Vascular Technology, Inc: Consultant or Advisor
Steven Shichman, MD: Nothing to disclose
Chandru P. Sundaram, MD: Nothing to disclose
Raju Thomas, MD, FACS, MHA: Gulf South Lithotripsy: Board Member, Officer, Trustee; Intuitive Surgical: Meeting Participant or Lecturer; AUA Journal of Urology Editorial Board: Board Member, Officer, Trustee; AUA Annual CME Courses: Meeting Participant or Lecturer; Journal of Endourology: Other: Reviewer; Journal of Urology: Board Member, Officer, Trustee; Urology Gold Journal: Other: Reviewer

2015 Reviewers:
James Frederic Borin ,M.D.: Journal of Endourology, Videourology Part B: Health Publishing; J Laparoendoscopic & Advanced Surgical Techniques Part B: Videoscopy: Health Publishing
James Andrew Brown MD: Dendreon: Consultant or Advisor; Myriad Genetics: Consultant or Advisor; MDxHealth: Consultant or Advisor
Erik P. Castle ,M.D.: Bayer: Consultant or Advisor
Matthew T. Gettman, MD: Nothing to Disclose
Jihad H. Kaouk, MD: Endocare: Meeting Participant or Lecturer
Chester J. Koh ,M.D.: Nothing to Disclose
Vincent P. Laudone ,M.D.: Guidepoint Global: Consultant or Advisor
Benjamin R. Lee, MD: Porges: Consultant or Advisor; Floshield: Scientific Study or Trial; Argos: Scientific Study or Trial
Jason Young Lee ,M.D.: Nothing to Disclose
Thomas Sean Lendvay ,M.D.: Spi Surgical Inc.: Consultant or Advisor, Owner, Product Development; CSATS, Inc.: Consultant or Advisor, Investment Interest, Owner, Product Development
Ravi Munver MD: Nothing to Disclose
Gyan Pareek, MD: BARD: Meeting Participant or Lecturer; Cook: Consultant or Advisor; Retrophin: Consultant or Advisor
James Roscoe Porter ,M.D.: Intuitive Surgical: Meeting Participant or Lecturer; B and K Medical: Meeting Participant or Lecturer; Surgiquest: Scientific Study or Trial
Chandru P. Sundaram, M.D.: Journal of Endourology and Videourology: Leadership Position; Sonacare Inc.: Scientific Study or Trial; OnTarget Inc: Scientific Study or Trial; IAUA: Leadership Position
Ashutosh Kumar Tewari MD: Intuitive Surgical: Scientific Study or Trial; Kalyani Prostate Cancer Institute: Leadership Position; Global Prostate Cancer Foundation: Leadership Position; Peter Georgescu Foundation Award: Leadership Position; Chris Lange Foundation: Other; Peter Kalikow Foundation: Other; Craig Effron Foundation: Other; Tim O'Neill Foundation: Other; Patent for a Catheter-less device and approach: Other: NIH RO1 Funding-PI: Other
Andrew A. Wagner, M.D.: Canary Foundation: Scientific Study or Trial

2017 Reviewers: 
Timothy Charles Brand, M.D.: Nothing to disclose
Arnold Chin ,MD: Nothing to disclose
John Warren Davis, MD: Genprobe: Scientific Study or Trial; Janssen: Scientific Study or Trial; Myriad Genetics: Consultant or Advisor, Meeting Participant or Lecturer; GenomeDx: Scientific Study or Trial; British Journal of Urology International: Health Publishing
David Duchene, MD: Intuitive Surgical, Inc: Meeting Participant or Lecturer, Scientific Study or Trial
Matthew Thomas Gettman, M.D.: COVR Medical: Consultant or Advisor; Intuitive Surgical: Consultant or Advisor; Exact Sciences: Scientific Study or Trial
Reza Ghavamian, MD: Ethicon: Consultant or Advisor
Ashok Kumar Hemal MD: Nothing to disclose
Jim C. Hu ,MD: Genomic Health: Meeting Participant or Lecturer
Brian Hilbert Irwin, MD: Nothing to disclose
Jihad H. Kaouk, MD: Endocare: Meeting Participant or Lecturer; Intuitive: Consultant or Advisor
Costas D. Lallas, MD: Nothing to disclose
Vincent P. Laudone ,MD: Guidepoint Global: Consultant or Advisor
Jason Young Lee, MD: Cook Medical: Other
Thomas Sean Lendvay MD: CSATS, Inc.: Consultant or Advisor, Investment Interest, Owner, Product Development
Peter Anthony Pinto ,MD: Nothing to disclose
Ashutosh Kumar Tewari, M.D: Intuitive Surgical: Scientific Study or Trial; Kalyani Prostate Cancer Institute: Leadership Position: Global Prostate Cancer Foundation: Leadership Position; Patent for a Catheter-less device and approach: Other; NIH RO1 Funding-PI: Other; Promaxo: Leadership Position
Ramakrishna Venkatesh: Nothing to disclose

Planner Disclosures:

Course Co-Directors:
Chandru P. Sundaram, MD: Nothing to disclose
Mani Menon, MD: Nothing to disclose

Editor:
Elspeth M. McDougall, MD, FRCSC, MHPE: Endocare: Other: Unrestricted Grant; Ethicon Endo-Surgery: Other: Equip Support-MIS Educ Center @ UCI; Intuitive Surgical: Other: Equip Support-MIS Educ Center @ UCI; Karl Storz Endoscopy America: Other: Equip Support-MIS Educ Center @ UCI; METI, Inc: Scientific Study or Trial; Simbionix: Other: Equip Support-MIS Educ Center @ UCI

Consultant:
Stephen Y. Nakada, MD: Nothing to disclose

Laparoscopic, Robotic & New Surgical Technology Committee:
David Mois Albala MD: Applied Medical: Investment Interest; Genomic Health: Consultant or Advisor, Scientific Study or Trial; Myriad: Meeting Participant or Lecturer; Cellanyx: Consultant or Advisor, Scientific Study or Trial
Marc A Bjurlin, DO: Nothing to disclose
Timothy Charles Brand, M.D.: Nothing to disclose
Arnold Chin ,MD: Nothing to disclose
John Warren Davis, MD: Genprobe: Scientific Study or Trial; Janssen: Scientific Study or Trial; Myriad Genetics: Consultant or Advisor, Meeting Participant or Lecturer; GenomeDx: Scientific Study or Trial; British Journal of Urology International: Health Publishing
Jody Donaldson: Nothing to disclose
David Duchene, MD: Intuitive Surgical, Inc: Meeting Participant or Lecturer, Scientific Study or Trial
Shelby Englert: Nothing to disclose
Matthew Thomas Gettman, M.D.: COVR Medical: Consultant or Advisor; Intuitive Surgical: Consultant or Advisor; Exact Sciences: Scientific Study or Trial
Reza Ghavamian, MD: Ethicon: Consultant or Advisor
Ashok Kumar Hemal MD: Nothing to disclose
Jim C. Hu ,MD: Genomic Health: Meeting Participant or Lecturer
Brian Hilbert Irwin, MD: Nothing to disclose
Jihad H. Kaouk, MD: Endocare: Meeting Participant or Lecturer; Intuitive: Consultant or Advisor
Costas D. Lallas, MD: Nothing to disclose
Vincent P. Laudone ,MD: Guidepoint Global: Consultant or Advisor
Jason Young Lee, MD: Cook Medical: Other
Thomas Sean Lendvay MD: CSATS, Inc.: Consultant or Advisor, Investment Interest, Owner, Product Development
Lori B. Lerner, MD: Lumenis, Inc.: Meeting Participant or Lecturer; Boston Scientific: Consultant or Advisor; Procept: Other
Peter Anthony Pinto ,MD: Nothing to disclose
Jonathan N. Rubenstein, MD FAC: Nothing to disclose
Ashutosh Kumar Tewari, M.D: Intuitive Surgical: Scientific Study or Trial; Kalyani Prostate Cancer Institute: Leadership Position; Global Prostate Cancer Foundation: Leadership Position; Patent for a Catheter-less device and approach: Other; NIH RO1 Funding-PI: Other; Promaxo: Leadership Position
Ramakrishna Venkatesh: Nothing to disclose

Education Council: 
Timothy Charles Brand, M.D.: Nothing to disclose
Anthony A. Caldamone MD: Nothing to disclose
Peter Robert Carroll, MD, MPH: NIH: Scientific Study or Trial; Department of Defense: Scientific Study or Trial; AUA Update: Leadership Position; Genomic Health: Scientific Study or Trial
Matthew S. Christman MD: Nothing to disclose
John D. Denstedt MD: Cook Urology: Owner, Product Development; Endourological Society: Leadership Position; Endourological Society: Health Publishing; Interface Biologics: Consultant or Advisor
Jody Donaldson: Nothing to disclose
Shelby Englert: Nothing to disclose
Allen Gao MD, PhD: Pandomedx: Leadership Position, Owner, Product Development
Matthew Thomas Gettman, M.D.: COVR Medical: Consultant or Advisor; Intuitive Surgical: Consultant or Advisor; Exact Sciences: Scientific Study or Trial
Inderbir Singh Gill ,MD, M.Ch.: Nothing to disclose
Howard B. Goldman, MD: allergan: Consultant or Advisor; Medtronic: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Cook: Scientific Study or Trial; Nuvectra: Consultant or Advisor; Axonics: Consultant or Advisor; NewUro: Consultant or Advisor
William C. Huang, MD: Photocure: Scientific Study or Trial; Karl Storz: Scientific Study or Trial
William C. Hulbert Jr. MD: Nothing to disclose
Brant Inman, M.D., MS, FRCSC: Dendreon: Scientific Study or Trial; Abbott Laboratories: Scientific Study or Trial; Genentech Inc: Scientific Study or Trial; Combat Medical: Consultant or Advisor, Scientific Study or Trial; FKD Therapies: Scientific Study or Trial; BioCancell: Consultant or Advisor; Nucleix: Scientific Study or Trial; Urogen: Scientific Study or Trial
Mark L. Jordan MD,FACS: Nothing to disclose
Martin A. Koyle MD: Nothing to disclose
Yair Lotan ,MD: abbott: Scientific Study or Trial; Cepheid: Consultant or Advisor, Scientific Study or Trial; Pacific Edge: Scientific Study or Trial; FKD: Scientific Study or Trial; MDxHealth: Consultant or Advisor, Scientific Study or Trial; biocancell: Scientific Study or Trial; Genomic Health: Scientific Study or Trial; GenomeDx Biosciences Inc: Scientific Study or Trial; photocure: Consultant or Advisor, Scientific Study or Trial
Nicole Lara Miller ,MD: Boston Scientific Corporation: Consultant or Advisor, Meeting Participant or Lecturer; Practical Reviews In Urology: Health Publishing
Manoj Monga, MD, FACS: Fortec: Other
Curtis Nickel, MD: Farr Laboratories: Consultant or Advisor; Tribute: Consultant or Advisor; Aquinox: Scientific Study or Trial; GSK: Scientific Study or Trial; PureTech Health: Consultant or Advisor; AUA: Health Publishing; NIH: Scientific Study or Trial; Canadian Institute of Health Research: Scientific Study or Trial; Interface Biologics: Consultant or Advisor; Alvio Therapeutics: Consultant or Advisor; Seikagaku Corporation: Consultant or Advisor
Victor William Nitti MD: Astellas: Health Publishing, Scientific Study or Trial; Allergan: Health Publishing, Scientific Study or Trial; Serenity Pharmeuticals: Investment Interest; Cook Myosite: Scientific Study or Trial; Medtronic: Scientific Study or Trial
Christopher Porter, MD: Nothing to disclose
Ganesh V. Raj MD, PhD: Ptares: Owner, Product Development; C-diagnostics corp: Consultant or Advisor, Investment Interest; amgen: Meeting Participant or Lecturer; Johnson and Johnson: Consultant or Advisor, Owner, Product Development; Astellas: Meeting Participant or Lecturer; ASTELLAS: Consultant or Advisor, Meeting Participant or Lecturer; Janssen: Owner, Product Development; BAYER: Consultant or Advisor, Meeting Participant or Lecturer; SANOFI: Consultant or Advisor, Meeting Participant or Lecturer; GaudiumRx: Leadership Position, Investment Interest, Owner, Product Development; Medivation: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; EtiraRx: Leadership Position, Investment Interest, Owner, Product Development
Jay D. Raman, MD: American Kidney Stone Management: Investment Interest; Pacific Edge Biotechnology: Consultant or Advisor, Scientific Study or Trial
Lee Richstone, MD: Nothing to disclose
Heather Schultz, NP: SUNA: Meeting Participant or Lecturer; SUNA: Leadership Position
Karl-Dietrich Sievert: AMS: Meeting Participant or Lecturer; Medtronics: Meeting Participant or Lecturer, Scientific Study or Trial; Allergen: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Neotract: Meeting Participant or Lecturer; Stimguard: Meeting Participant or Lecturer, Scientific Study or Trial
Joseph A. Smith Jr.,MD: Nothing to disclose
Ryan Patrick Terlecki, MD, FACS: American Medical Systems: Consultant or Advisor, Other; Allergan: Scientific Study or Trial
Edouard John Trabulsi, MD, FACS: GenomeDx: Consultant or Advisor

Method of Participation

  • Pre-requisite: the participant must complete Intuitive Surgical's Online Training System at www.daVinciSurgeryCommunity.com and provide a certificate of completion upon request.
  • To earn CME credit/hours of participation, the participant must complete all modules, including all content areas, videos and posttests, passing with at least 80% accuracy, and submit an online evaluation and credit claim for each module. Modules 1-5 are mandatory and all must be completed to claim credit for the Fundamentals and Basic Procedures certificate.

Estimated time to complete this activity 1.5 hours

Release Date: February, 2012
Peer Review: This activity was peer reviewed October, 2017
Expiration Date December, 2020

Accreditation Statement

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American Urological Association designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. If you have already received credit for this course by attending it or watching it live you cannot receive additional credit.

AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Evidence-Based Content

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

Off-label or Unapproved Use of Drugs or Devices

It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.

AUA Privacy and Confidentiality Policy

www.auanet.org/education/confidentiality-statement.cfm

Contact Information

American Urological Association
Office of Education
1000 Corporate Blvd.
Linthicum, MD 21090

Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282)
Phone: 410-689-3700
Fax: 410-689-3800

CME Information

For all inquiries regarding CME credit email: cme@AUAnet.org

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation

Accreditation Period

Course opens: 
12/12/2017
Course expires: 
12/12/2020
Please login or register to take this course.